STARLIMS
an Abbott-owned brand relaunched independently under Francisco Partners in 2021, offering a cloud LIMS with guided execution ("QM Essentials") targeted at small-to-medium batch-manufacturing QC labs.
- Country
- United States
US
Coverage
| CN | EU | US | |
|---|---|---|---|
| analytics-pat | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Laboratory execution systems (LES) | analytics-pat | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.